Vetnews | November 2026 36 « BACK TO CONTENTS Elevated CK-MB reflects myocardial cell membrane damage and leakage of cardiac enzymes into circulation, indicating the presence of diabetic cardiomyopathy. These findings are consistent with earlier studies demonstrating myocardial injury in experimental diabetic models (Youssef et al., 2022). Elevated creatine kinase–MB (CK-MB) activity in HFD– STZ–induced diabetes reflects hyperglycaemiamediated myocardial injury. Sustained hyperglycaemia enhances glucose flux into cardiomyocytes, leading to excessive generation of reactive oxygen species through mitochondrial dysfunction, increased polyol pathway activity, and accelerated formation of advanced glycation end products. The resulting oxidative stress promotes lipid peroxidation of cardiomyocyte membranes, increasing membrane permeability and facilitating the release of CK-MB into the circulation (Ansley and Wang, 2013). In parallel, activation of IKK-dependent NF-κB signalling amplifies inflammatory and profibrotic responses, contributing to cardiomyocyte apoptosis, hypertrophy, and progressive cardiac dysfunction. Such mechanisms collectively underpin the elevation of CK-MB as a sensitive biochemical indicator of diabetes associated myocardial damage. In the HFD+STZ model, persistent hyperglycemia promotes the formation of advanced glycation end-products (AGEs) and reactive oxygen species, leading to oxidative damage of the cardiac sarcolemma. This loss of membrane integrity allows the leakage of the intracellular CK-MB isoenzyme into the systemic circulation, serving as a definitive marker of myocardial injury and diabetic cardiomyopathy (Cai and Kang, 2003) in rats. 3.7 Effect of high-fat diet and STZ on body weight Normal control rats exhibited a gradual increase in body weight throughout the experimental period. In contrast, HFD–STZ–treated rats (Table 5) showed an initial increase in body weight following HFD feeding, followed by a significant (p<0.01) reduction after STZ administration. Progressive weight loss was evident by day 14 and day 28, despite persistent hyperglycaemia. This reduction in body weight may be attributed to enhanced proteolysis, lipolysis, and impaired glucose utilisation, reflecting systemic metabolic dysfunction associated with diabetes (Tam et al., 2024). Body weight alterations in HFD–STZ–induced diabetes are primarily attributed to insulin deficiency–and insulin resistance–associated metabolic disturbances. Impaired insulin action promotes enhanced proteolysis and lipolysis, leading to negative energy balance and progressive weight loss despite adequate nutritional intake. Similar reductions in body weight have been consistently reported in streptozotocin-induced and HFD–STZ diabetic models, reflecting disrupted metabolic regulation and increased catabolic activity characteristic of experimental Type 2 diabetes (Huang et al., 2024). Consistent with the findings of Akbarzadeh et al. (2007), rats rendered diabetic with streptozotocin showed a marked decline in body weight when compared to non-diabetic controls. This reduction may be attributed to insulin deficiency–induced metabolic disturbances, leading to enhanced breakdown of proteins and lipids and loss of body mass. In the HFD+STZ model, an initial increase in body weight during the HFD phase is followed by a significant decline post-STZ administration. This weight loss is driven by the depletion of fat and muscle stores through accelerated catabolism and the massive loss of calories and fluids through glucose-induced osmotic diuresis (Srinivasan et al., 2005) Group Before the administration of HFD On the day of administration of STZ (Day zero) Day 4 Day 14 Day 28 Normal animals (Group I) 0.27±0.01aA 0.27±0.03aA 0.26±0.02aA 0.27±0.01aA 0.27±0.01aA Animals fed with HFD and STZ (Group II) 0.27±0.03aA 0.393±0.044bB 0.51±0.033cB 0.64 +0.11cB Animals fed with HFD and STZ (Group II) were extended till 28th day 0.21±0.02aA 0.28±002aA 0.35±0.34cC 0.46 +0.06cC 0.4 +0.03cB Table 4: Effect of high-fat diet and streptozotocin on the serum creatinine concentration of rats Table 5: Effect of high-fat diet and STZ on the body weight of rats Group Before the administration of HFD On the day of administration of STZ(Day zero) Day 4 Day 14 Day 28 Normal animals (Group I) 152.5±4.28a 161.5±4.25b 148.23±3.69a 162.48±2.43b 168.32±3.21b Animals fed with HFD and STZ (Group II) 156.5±4.66a 310.25±16.23b 305.25±16.23b 277.25±13.76c Animals fed with HFD and STZ (Group II) were extended till 28th day 176.5±10.15a 318±30b 306.25±30.11b 272±13.27c 238.5±4.03d >>>37 Article
RkJQdWJsaXNoZXIy OTc5MDU=